Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Hemoglobin|November 24, 1999
Hb Aghia Sophia [alpha62(E11)Val-->0 (alpha1)], an "in-frame" deletion causing alpha-thalassemiaJ Traeger-Synodinos, C L Harteveld, E Kanavakis, et al.
Journal of Pediatric Hematology/Oncology|April 17, 1999
Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurementsO Papakonstantinou, S Kostaridou, T Maris, et al.
British Journal of Haematology|December 1, 1979
Occurrence of G gamma Hb F in Greek HPFH: analysis of heterozygotes and compound heterozygotes with beta thalassaemiaJ B Clegg, A Metaxatou-Mavromati, C Kattamis, et al.
British Journal of Haematology|December 22, 1999
Molecular, haematological and clinical studies of the -101 C --> T substitution of the beta-globin gene promoter in 25 beta-thalassaemia intermedia patients and 45 heterozygotesE Maragoudaki, E Kanavakis, J Traeger-Synodinos, et al.
British Journal of Haematology|December 1, 1996
The triplicated alpha-globin gene locus in beta-thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studiesJ Traeger-Synodinos, E Kanavakis, C Vrettou, et al.
Hemoglobin|June 18, 1998
An alpha-thalassemic hemoglobinopathy: homozygosity for the HB Agrinio alpha 2-globin chain variantJ Traeger-Synodinos, A Metaxotou-Mavromati, E Kanavakis, et al.
Human Genetics|September 1, 1995
Mutation analysis of ten exons of the CFTR gene in Greek cystic fibrosis patients: characterization of 74.5% of CF alleles including one novel mutationE Kanavakis, M Tzetis, T Antoniadi, et al.
British Journal of Haematology|February 1, 1996
The interaction of alpha zero thalassaemia with Hb Icaria: three unusual cases of haemoglobinopathy HE Kanavakis, J Traeger-Synodinos, I Papasotiriou, et al.
British Journal of Haematology|December 21, 2000
Phenotypic and molecular diversity of haemoglobin H disease: a Greek experienceE Kanavakis, I Papassotiriou, M Karagiorga, et al.
Vaccine|July 18, 2001
Reactogenicity of DTPa-HBV/Hib vaccine administered as a single injection vs DTPa-HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of ageF Omeñaca, R Dal-Ré, V D'Apuzzo, et al.
Pageof 9